WuXi Biologics
Offering End-to-End Solutions
Technology platforms that span the entire drug discovery to manufacturing spectrum.
A WuXi Biologics subsidiary, greatly simplifies bioconjugate development and manufacturing.
One-stop target identification to lead preclinical candidate (PCC) platform.
Unparalleled capacities and expertise for the discovery, development and cGMP manufacture of biologics from concept to commercialization.
Providing extensive expertise and high-quality biosafety testing under EMA, ISO (CNAS) and CMA certified laboratories.
E.coli and yeast based expression systems, process development and cGMP manufacturing platform
World-class quality systems approved by the U.S. FDA, EMA and NMPA.
Viral vector based vaccine and therapeutic virus development and cGMP manufacturing platform.
Total estimated capacity for biopharmaceutical production in China, Ireland, the U.S., Germany and Singapore to exceed 580,000 liters by 2026.
We provide quality assurance, quality control and operational systems that meet or exceed worldwide regulatory standards. Our premier world-class quality systems have been approved by multiple global regulatory agencies for a wide variety of biologics and vaccines.
GMP Facilities Certified
Audits from Different Global Regulatory Agencies
Successful Regulatory Agency Inspections
Successful Client Quality Audits
We are dedicated to implementing sustainable and eco-friendly business practices by building a comprehensive and integrated Environmental, Health and Safety (EHS) management system, sourcing ethically, reducing our environmental footprint, advocating reduced energy consumption, minimizing effluent, and acting responsibly to reduce operational impact on the environment.
WuXi Biologics offers exciting job opportunities and careers around the globe. Come be a part of our PROUD (Passion, Reward, Ownership, Unity & Determination) culture and embrace the challenges and new opportunities as we work together to enable our clients and benefit patients worldwide.
Stay up-to-date on our latest news, financial results and capabilities at our sites around the globe!
